Home
Hisun Pharmaceuticals

Hisun Pharmaceuticals Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainhisunpharm.com

Year Founded1956

Employees1001 - 5000

Annual Revenue> $1B

Hisun Pharmaceuticals

Hisun Pharmaceuticals (including company regionals)

hisunpharm.com

See more website traffic and engagement information

Hisun Pharmaceuticals Revenue up to June 2026 is > 1B

revenue generated by Hisun Pharmaceuticals top domains

Hisun Pharmaceuticals top domains revenue over 3 years

Revenue for Hisun Pharmaceuticals top domains

hisunpharm.com> 1B

See more with Sales Intelligence

Total visits to Hisun Pharmaceuticals's top domains

Understand Hisun Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hisunpharm.com116.4K

See more with Sales Intelligence

Avg. visit duration in Hisun Pharmaceuticals's top domains

Analyze Hisun Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hisunpharm.com00:04:28

See more with Sales Intelligence

Avg. pageviews on Hisun Pharmaceuticals's top domains

See how Hisun Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hisunpharm.com6.91

See more with Sales Intelligence

Hisun Pharmaceuticals top competitors by domain

Top similar sites in June 2026, ranked by their affinity

fosunpharma.comCompany NameFosun PharmaEmployees> 10001HQChina, ShanghaiAnnual revenue> $1BTotal visits29.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Hisun Pharmaceuticals

These are the website technologies, by industry, used by Hisun Pharmaceuticals top domains

Advertising (4)

PubMatic

Email Services (1)

QQ Mail

Mobile (1)

Meta Viewport

Other (1)

Google API

More Technologies

1

See all

News & Signals from Hisun Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHisunpharm partnered with Eli Lilly on May 29th '26.Within a single day, Hisun Pharmaceuticals received FDA approval for its cyclopropanol product and subsequently signed a global research and development agreement with Eli Lilly.

NewsInfectious Disease Research Institute partnered with Hisunpharm on Aug 24th '17.IDRI (Infectious Disease Research Institute), on behalf of the Lilly TB Drug Discovery Initiative, announces it has entered into an agreement with Zhejiang Hisun Pharmaceutical Co., Ltd., a China -based leading biopharmaceutical company, to continue development of inhalable CPZEN-45, a tuberculosis (TB) drug candidate that could potentially treat the growing problem of antibiotic-resistant TB.